Guardant Health scores about $50 mln Series C
Redwood City, California-based Guardant Health, a cancer testing provider, has closed about $50 million in Series C funding. Lightspeed Venture Partners led the round with participation from Formation 8 and previous backers Khosla Ventures and Sequoia Capital.
3 February 2015•4 mins read
